मर्क एंड कंपनी

मुक्त ज्ञानकोश विकिपीडिया से
मर्क एंड कंपनी
(Merck Sharp & Dohme (MSD) outside the United States and Canada)
प्रकार Public (NYSE: MRK)
Dow Jones Industrial Average Component
उद्योग Pharmaceuticals
स्थापना 1891 as a subsidiary of Merck KGaA
1917 as an independent company
मुख्यालय Whitehouse Station, New Jersey, United States
प्रमुख व्यक्ति

Richard T. Clark,
Chairman of the Board
Kenneth Frazier, President and CEO
Stanley F. Barshay, EVP and president, Consumer Health Care
Adam H. Schechter, president, Global Human Health
Richard S. Bowles, Ph.D., chief compliance officer
Willie A. Deese, EVP and president, Merck Manufacturing
Mirian Graddick-Weir, Ph.D., EVP, Human Resources
Peter N. Kellogg, chief financial officer
Peter S. Kim, Ph.D., EVP and president, Merck Research Laboratories
Raul E. Kohan, president, Animal Health
Bruce N. Kuhlik, general counsel
J. Chris Scalet, chief information officer, Global Services

Mervyn Turner, Ph.D, chief strategy officer
उत्पाद

Gardasil
Singulair
Propecia/Proscar
Zocor Vioxx Fosamax

See more complete products listing.
राजस्व वृद्धि US$27.4 Billion (FY 2009)[1]
प्रचालन आय वृद्धि US$4.83 Billion (FY 2009)[1]
निवल आय वृद्धि US$12.9 Billion (FY 2009)[1]
कुल संपत्ति वृद्धि US$112 Billion (FY 2009)[2]
कुल इक्विटी वृद्धि US$59.1 Billion (FY 2009)[2]
कर्मचारी 61,500 (2005)
वेबसाइट merck.com

सन्दर्भ[संपादित करें]